Arbutus Biopharma Corp — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
20-F
20-F/A
3
3/A
4
4/A
424B2
424B5
6-K
6-K/A
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DEFR14A
EFFECT
F-10
F-10/A
F-X
FWP
NT 10-K
PRE 14A
PREM14A
PRER14A
REGDEX
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SUPPL
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001447028-23-000018 | Mar 2, 2023 | Dec 31, 2022 |
| 4 | FORM 4 | 0001447028-23-000009 | Feb 3, 2023 | Feb 1, 2023 |
| 4 | FORM 4 | 0001447028-23-000007 | Feb 3, 2023 | Feb 1, 2023 |
| 4 | FORM 4 | 0001447028-23-000010 | Feb 3, 2023 | Feb 1, 2023 |
| SC 13G | — | 0001306550-23-007128 | Feb 3, 2023 | — |
| 4 | FORM 4 | 0001447028-23-000011 | Feb 3, 2023 | Feb 1, 2023 |
| 4 | FORM 4 | 0001447028-23-000008 | Feb 3, 2023 | Feb 1, 2023 |
| 8-K | FORM 8-K | 0001171843-23-000518 | Jan 27, 2023 | Jan 23, 2023 |
| 8-K | FORM 8-K | 0001171843-23-000071 | Jan 5, 2023 | — |
| 8-K | FORM 8-K | 0001171843-22-008011 | Dec 13, 2022 | — |
| 10-Q | 10-Q | 0001447028-22-000055 | Nov 9, 2022 | Sep 30, 2022 |
| 8-K | FORM 8-K | 0001171843-22-007260 | Nov 9, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-007106 | Nov 4, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-006961 | Nov 1, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-006904 | Oct 31, 2022 | — |
| 8-K | 8-K | 0001447028-22-000051 | Oct 24, 2022 | Oct 18, 2022 |
| 8-K | FORM 8-K | 0001171843-22-006328 | Sep 30, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-005860 | Aug 30, 2022 | — |
| 10-Q | 10-Q | 0001447028-22-000047 | Aug 4, 2022 | Jun 30, 2022 |
| S-8 | S-8 | 0001447028-22-000049 | Aug 4, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-005343 | Aug 4, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-004906 | Jul 20, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-004546 | Jun 27, 2022 | Jun 25, 2022 |
| 8-K | FORM 8-K | 0001171843-22-004212 | Jun 8, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-004157 | Jun 6, 2022 | — |
| 8-K | 8-K | 0001447028-22-000041 | May 31, 2022 | May 25, 2022 |
| 4 | FORM 4 | 0001447028-22-000038 | May 26, 2022 | May 25, 2022 |
| 8-K | FORM 8-K | 0001171843-22-003988 | May 26, 2022 | — |
| 4 | FORM 4 | 0001447028-22-000034 | May 26, 2022 | May 25, 2022 |
| 4 | FORM 4 | 0001447028-22-000035 | May 26, 2022 | May 25, 2022 |
| 4 | FORM 4 | 0001447028-22-000033 | May 26, 2022 | May 25, 2022 |
| 4 | FORM 4 | 0001447028-22-000036 | May 26, 2022 | May 25, 2022 |
| 4 | FORM 4 | 0001447028-22-000037 | May 26, 2022 | May 25, 2022 |
| 8-K | FORM 8-K | 0001171843-22-003897 | May 24, 2022 | — |
| 10-Q | 10-Q | 0001447028-22-000025 | May 5, 2022 | Mar 31, 2022 |
| 8-K | FORM 8-K | 0001171843-22-003268 | May 5, 2022 | — |
| DEF 14A | DEF 14A | 0001140361-22-013967 | Apr 11, 2022 | May 25, 2022 |
| DEFA14A | DEFA14A | 0001140361-22-013976 | Apr 11, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-001596 | Mar 3, 2022 | — |
| 10-K | 10-K | 0001447028-22-000019 | Mar 3, 2022 | Dec 31, 2021 |
| 424B5 | 424B5 | 0001104659-22-030106 | Mar 3, 2022 | — |
| 8-K | FORM 8-K | 0001104659-22-030110 | Mar 3, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-001419 | Feb 28, 2022 | — |
| SC 13G/A | ARBUTUS BIOPHARMA CORPORATION | 0000902664-22-001628 | Feb 14, 2022 | — |
| 8-K | FORM 8-K | 0001171843-22-000411 | Jan 24, 2022 | — |
| 4 | FORM 4 | 0001447028-22-000009 | Jan 20, 2022 | — |
| 4 | FORM 4 | 0001447028-22-000007 | Jan 20, 2022 | — |
| 4 | FORM 4 | 0001447028-22-000008 | Jan 20, 2022 | — |
| 4 | FORM 4 | 0001447028-22-000010 | Jan 20, 2022 | — |
| 4 | FORM 4 | 0001447028-22-000011 | Jan 20, 2022 | — |